
Cecil Pharmaceuticals Private Limited
About Cecil Pharmaceuticals Private Limited
Data last updated:
Cecil Pharmaceuticals Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24231JK1996PTC001523. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.56 Cr. It is led by directors Indukuri Subba Raju and Karanam Venkataapparao.
Its last annual general meeting (AGM) was held on 30 September 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office is at Plot No. 2 3 8 & 9 Epip SIDCO Kartholi Bari Brahmana, Jammu, Jammu and Kashmir, India – 181133.
As per MCA filings, the company has open charges of ₹5.95 Cr and satisfied charges of ₹10 Cr on record. Court records list 24 cases involving the company, including 1 filed by the company and 23 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Cecil Pharmaceuticals Private Limited's registered office is in Jammu, Jammu And Kashmir.
- Registered AddressPlot No. 2 3 8 & 9 Epip SIDCO Kartholi Bari Brahmana, Jammu, Jammu and Kashmir, India – 181133
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cecil Pharmaceuticals Private Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Cecil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cecil Pharmaceuticals Private Limited
Cecil Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indukuri Subba Raju Also directs: Sanvi Organics Private Limited, American Solutions Private Limited | Additional Director | 14 Jul 2010 | 16 Years 3 Months | Current |
| Karanam Venkataapparao Also directs: Sanvi Organics Private Limited, Tasvi Hospitality Private Limited | Additional Director | 14 Jul 2010 | 16 Years 3 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Nov 2006 | 10030101 | State Bank of India | ₹4.95 Cr | Open | |
| 16 Nov 2006 | 10030121 | State Bank of India | ₹1 Cr | Open | |
| 13 Oct 2010 | 10247171 | Uco Bank | ₹10 Cr | Satisfied |
To see the full charge records of Cecil Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Cecil Pharmaceuticals Private Limited has 24 court cases on record: 1 filed by Cecil Pharmaceuticals, 23 filed against it. 1 case is pending and 23 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 22 | 1 |
| High courts | 1 | 1 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Criminal miscellaneous application | Filed against the company by M/S Parabolic Drugs Ltd | Disposed |
| High Court | Court case (OWP) | Filed against the company by Status Projects Pvt. Ltd. Th. Pranav Shankar Tripathi. | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Ms Nectar Life Sciences Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by M/S Shubham Pharmachem Pvt Ltd | Disposed |
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by DSM Anti Infectives India Ltd. | Disposed |
To see the full case history of Cecil Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cecil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cecil Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cecil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cecil Pharmaceuticals Private Limited has 12 board changes on record since 2010: 2 appointments and 10 cessations. The latest: Venkata Rama Raju Indukuri ceased to be Additional Director on 01 Sep 2011.
9 earlier events are in the company report.
Frequently asked questions
Cecil Pharmaceuticals is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 1996 (30+ years old) and is registered under CIN U24231JK1996PTC001523.
Cecil Pharmaceuticals has 2 current directors:
- Indukuri Subba Raju - Additional Director
- Karanam Venkataapparao - Additional Director
The latest financial statements of Cecil Pharmaceuticals on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 30 September 2010. Year-wise statements from 2015 are in the company report.
No. Cecil Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Cecil Pharmaceuticals is U24231JK1996PTC001523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cecil Pharmaceuticals has 24 court cases on record: 1 filed by the company and 23 filed against it. 1 is pending. Most are in the district courts.
Cecil Pharmaceuticals was incorporated on 19 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Jammu.
Venkata Rama Raju Indukuri ceased to be Additional Director on 01 Sep 2011. Neeraj Srivastava ceased to be Additional Director on 26 May 2011. Jairamdas Badlani ceased to be Director on 28 Feb 2011. Cecil Pharmaceuticals has 12 board changes on record in total.
The registered office of Cecil Pharmaceuticals is at Plot No. 2 3 8 & 9 Epip SIDCO Kartholi Bari Brahmana, Jammu, Jammu and Kashmir, India – 181133.
Cecil Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

